Intarcia Therapeutics
ID: 3940974Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.
4
Funding Rounds
$479.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Co**** | - | - | linkedin facebook |
| Na*** Th******** | - | - | |
| Ku** Gr**** |
|
- | - |
| Ja* S. Sk**** | - | - | - |
| Gi** Sa***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Intarcia Therapeutics has raised a total of $479.49m in funding over 4 rounds.
Key Insights:
- Intarcia Therapeutics series E funding round: $200m
- Intarcia Therapeutics , September 2016: $215m
- Intarcia Therapeutics funding round, May 2010: $14.49m
- Intarcia Therapeutics Series B round: $50m
Industries
Intarcia Therapeutics is active in the following industries: